Thunder Good-Oil
Well-Known Member
- Joined
- Dec 2, 2011
- Messages
- 47,458
- Likes
- 49,402
Well, your EPS of $3.22 is GAAP trailing. The non-gaap estimated fiscal 4/2023 eps is $5.25 to $5.30. This was the last updated guidance by MDT on 11/22/22. In their case, there are big differences between gaap and non-gaaap because a court case required them to book a $764 million expense within this last quarter. When calculating the payout ratios, do you think we should go strictly by gaap or use non-gaap? You'll see different analysts using both. Both can be distorted and misleading. In this case, the non-gaap eps makes the payout ratio around 52%. I usually like between 40% and 60% payout for my div picks. MDT's 52% is not bad when one considers the overall situation. Forty four years of div increases is strong. Maybe they cant increase it like they have. The pandemic may have disrupted them too much but I doubt they reduce.
I’d always use GAAP. Too often companies’ managements are polishing turds. With non-GAAP arguments there’s potential for manipulation in some period. Eventually it’s all going to hit. A reason that I don’t trust broadcasters numbers so much. They like to ignore big pieces of the picture. Eventually, rebuilding studios and other CapEx and putting large pieces (FCC licenses and broadcast towers for example) of over priced acquisitions on balance sheets needs to fall onto P&Ls. EBITDA ignores big pieces.
If MDT can keep booking $5 or better GAAP then I wouldn’t worry about such a high payout. As long as other hidden expenses don’t pop up. They also carry net debt of a bit under $20 billion. I wonder how rich their inventory carrying value might be. Revenue is just a hair over $30 billion and grows around 5%. I’d be more worried about what will push up share prices with earnings not likely to meaningfully advance until about 5 more years out. Share price is where it was 20 years ago.
I’d like to hear what surgeons using da Vinci have to say about Hugo. A miss on that front would be painful for MDT. It seems like a bold move away from their core businesses. ISRG won’t necessarily refrain from aggressive moves to counter MDT moving onto their turf.
MDT is also more exposed to supply chain and staffing than a lot of the investment universe.
I wouldn’t be overly aggressive buying up shares. But it really wouldn’t scare me either to own shares for the LT.